Cargando…
A Long-Term Survivor With Alveolar Capillary Dysplasia
A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering p...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302120/ https://www.ncbi.nlm.nih.gov/pubmed/34317003 http://dx.doi.org/10.1016/j.jaccas.2020.05.055 |
_version_ | 1783726826923753472 |
---|---|
author | Yost, Chandler E. Putnam, Angelica R. Dishop, Megan K. Jorgensen, Lynda O. Wirkus, Paul E. Day, Ronald W. |
author_facet | Yost, Chandler E. Putnam, Angelica R. Dishop, Megan K. Jorgensen, Lynda O. Wirkus, Paul E. Day, Ronald W. |
author_sort | Yost, Chandler E. |
collection | PubMed |
description | A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering pulmonary arterial pressure and managing right heart failure. (Level of Difficulty: Beginner.) |
format | Online Article Text |
id | pubmed-8302120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83021202021-07-26 A Long-Term Survivor With Alveolar Capillary Dysplasia Yost, Chandler E. Putnam, Angelica R. Dishop, Megan K. Jorgensen, Lynda O. Wirkus, Paul E. Day, Ronald W. JACC Case Rep Mini-Focus Issue: Heart Failure A patient with alveolar capillary dysplasia has survived more than 56 months with medical therapy. Intrauterine exposure to metformin potentially modified the severity of disease. In combination with other agents, endothelin receptor antagonists and amlodipine have been key medications in lowering pulmonary arterial pressure and managing right heart failure. (Level of Difficulty: Beginner.) Elsevier 2020-07-29 /pmc/articles/PMC8302120/ /pubmed/34317003 http://dx.doi.org/10.1016/j.jaccas.2020.05.055 Text en © 2020 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Mini-Focus Issue: Heart Failure Yost, Chandler E. Putnam, Angelica R. Dishop, Megan K. Jorgensen, Lynda O. Wirkus, Paul E. Day, Ronald W. A Long-Term Survivor With Alveolar Capillary Dysplasia |
title | A Long-Term Survivor With Alveolar Capillary Dysplasia |
title_full | A Long-Term Survivor With Alveolar Capillary Dysplasia |
title_fullStr | A Long-Term Survivor With Alveolar Capillary Dysplasia |
title_full_unstemmed | A Long-Term Survivor With Alveolar Capillary Dysplasia |
title_short | A Long-Term Survivor With Alveolar Capillary Dysplasia |
title_sort | long-term survivor with alveolar capillary dysplasia |
topic | Mini-Focus Issue: Heart Failure |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302120/ https://www.ncbi.nlm.nih.gov/pubmed/34317003 http://dx.doi.org/10.1016/j.jaccas.2020.05.055 |
work_keys_str_mv | AT yostchandlere alongtermsurvivorwithalveolarcapillarydysplasia AT putnamangelicar alongtermsurvivorwithalveolarcapillarydysplasia AT dishopmegank alongtermsurvivorwithalveolarcapillarydysplasia AT jorgensenlyndao alongtermsurvivorwithalveolarcapillarydysplasia AT wirkuspaule alongtermsurvivorwithalveolarcapillarydysplasia AT dayronaldw alongtermsurvivorwithalveolarcapillarydysplasia AT yostchandlere longtermsurvivorwithalveolarcapillarydysplasia AT putnamangelicar longtermsurvivorwithalveolarcapillarydysplasia AT dishopmegank longtermsurvivorwithalveolarcapillarydysplasia AT jorgensenlyndao longtermsurvivorwithalveolarcapillarydysplasia AT wirkuspaule longtermsurvivorwithalveolarcapillarydysplasia AT dayronaldw longtermsurvivorwithalveolarcapillarydysplasia |